176 related articles for article (PubMed ID: 21486580)
21. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
[TBL] [Abstract][Full Text] [Related]
22. Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.
Toso C; Merani S; Bigam DL; Shapiro AM; Kneteman NM
Hepatology; 2010 Apr; 51(4):1237-43. PubMed ID: 20187107
[TBL] [Abstract][Full Text] [Related]
23. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma.
Vivarelli M; Dazzi A; Zanello M; Cucchetti A; Cescon M; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
Transplantation; 2010 Jan; 89(2):227-31. PubMed ID: 20098287
[TBL] [Abstract][Full Text] [Related]
24. [Liver transplantation for hepatocellular carcinoma and potential application of PSI].
Decaens T; Duvoux C
Gastroenterol Clin Biol; 2009 Nov; 33 Suppl 4():S257-62. PubMed ID: 20004332
[TBL] [Abstract][Full Text] [Related]
25. Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.
Koschny R; Schmidt J; Ganten TM
Clin Transplant; 2009 Dec; 23 Suppl 21():49-60. PubMed ID: 19930317
[TBL] [Abstract][Full Text] [Related]
26. [Liver transplantation for hepatocellular carcinoma].
Suh KS; Yi NJ
Korean J Hepatol; 2006 Dec; 12(4):493-506. PubMed ID: 17237627
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation and tacrolimus monotherapy for hepatocellular carcinoma with expanded criteria.
Dalgic A; Karakayali H; Moray G; Emiroglu R; Sozen H; Torgay A; Haberal M
Transplant Proc; 2005 Sep; 37(7):3154-6. PubMed ID: 16213334
[TBL] [Abstract][Full Text] [Related]
28. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
29. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
30. Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence.
Andreana L; Burroughs AK
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S249-57. PubMed ID: 20547311
[TBL] [Abstract][Full Text] [Related]
31. [Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
Gugenheim J; Baldini E; Casaccia M; Ouzan D; Saint-Paul MC; Mouiel J
Gastroenterol Clin Biol; 1997; 21(8-9):590-5. PubMed ID: 9587497
[TBL] [Abstract][Full Text] [Related]
32. Current role of surgery in treatment of early stage hepatocellular carcinoma: resection versus liver transplantation.
Yi NJ; Suh KS; Kim T; Kim J; Shin WY; Lee KU
Oncology; 2008; 75 Suppl 1():124-8. PubMed ID: 19092282
[TBL] [Abstract][Full Text] [Related]
33. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
[TBL] [Abstract][Full Text] [Related]
34. The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation.
Zimmerman MA; Kelly MA; Campsen J; Mandell MS; Wachs M; Bak T; Skibba A; Lancaster B; Kam I
Clin Transplant; 2010; 24(4):E103-8. PubMed ID: 20030681
[TBL] [Abstract][Full Text] [Related]
35. Sirolimus in liver transplant recipients: a large single-center experience.
Vivarelli M; Dazzi A; Cucchetti A; Gasbarrini A; Zanello M; Di Gioia P; Bianchi G; Tamè MR; Gaudio MD; Ravaioli M; Cescon M; Grazi GL; Pinna AD
Transplant Proc; 2010 Sep; 42(7):2579-84. PubMed ID: 20832548
[TBL] [Abstract][Full Text] [Related]
36. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
Toso C; Meeberg GA; Bigam DL; Oberholzer J; Shapiro AM; Gutfreund K; Ma MM; Mason AL; Wong WW; Bain VG; Kneteman NM
Transplantation; 2007 May; 83(9):1162-8. PubMed ID: 17496530
[TBL] [Abstract][Full Text] [Related]
37. [Liver transplantation: personalized immunosuppression in patients with hepatitis C virus infection and hepatocellular carcinoma].
Rubín A; Berenguer M
Gastroenterol Hepatol; 2013 Jan; 36(1):48-57. PubMed ID: 22578313
[TBL] [Abstract][Full Text] [Related]
38. Liver resection associated with mini porto-caval shunt as salvage treatment in patients with progression of hepatocellular carcinoma before liver transplantation: a case report.
Polacco M; Vitale A; Valmasoni M; D'Amico F; Gringeri E; Brolese A; Zanus G; Neri D; Carraro A; Pauletto A; Romanelli E; Lo Bello S; Cillo U
Transplant Proc; 2010 May; 42(4):1378-80. PubMed ID: 20534307
[TBL] [Abstract][Full Text] [Related]
39. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
[TBL] [Abstract][Full Text] [Related]
40. Effects of rapamycin in liver transplantation.
Chen YB; Sun YA; Gong JP
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):25-8. PubMed ID: 18234634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
